The cutoff for relative NRG1 mRNA expression in tumor tissue (1.353) provides the highest diagnostic performance, with specificity of 89.47% and sensitivity of 57.65%, rendering it valuable for confirming CRPC in challenging cases and refining risk stratification. This evidence concerns the gene NRG1 and neoplasm.